EHTH · eHealth, Inc. · Documents

Aug 7

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $65.86M ▼ 1.4% Net loss $27.97M Diluted EPS -$1.33

Jun 14

Current report 8-K Events of Jun 12

Director or officer change, or executive pay, Shareholder vote results

Jun 10

Proxy statement DEFA14A

Proxy statement

May 30

Current report 8-K Events of May 29

Director or officer change, or executive pay, Regulation FD disclosure

May 23

Proxy statement DEFA14A

Proxy statement

May 7

Earnings call

Q1 2024 earnings call

May 7

Current report 8-K

Financial results

May 7

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $92.96M ▲ 26.1% Net loss $16.98M Diluted EPS -$0.96

Apr 26

Proxy statement DEF 14A Meeting Jun 12, 2024

Proxy statement

Apr 26

Annual report to holders ARS

Annual report to holders

Apr 26

Proxy statement DEFA14A

Proxy statement

Feb 29

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $452.87M ▲ 11.7% Net loss $28.21M Diluted EPS -$2.37

Feb 27

Earnings call

Q4 2023 earnings call

Feb 27

Current report 8-K

Financial results

Jan 26

Current report 8-K

Financial results

Nov 20

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure

Nov 9

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $64.72M ▲ 21.2% Net loss $37.03M Diluted EPS -$1.68

Nov 8

Earnings call

Q3 2023 earnings call

Nov 8

Current report 8-K

Financial results

Aug 8

Earnings call

Q2 2023 earnings call

Aug 8

Current report 8-K

Financial results

Aug 8

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $66.77M ▲ 32.5% Net loss $23.5M Diluted EPS -$1.18

Jun 21

Current report 8-K Events of Jun 14

Shareholder vote results

May 9

Earnings call

Q1 2023 earnings call

May 9

Current report 8-K

Financial results

May 9

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $73.72M ▼ 30.0% Net loss $19.88M Diluted EPS -$1.01

May 1

Proxy statement DEF 14A

Proxy statement

May 1

Current report 8-K Events of Apr 28

Regulation FD disclosure

May 1

Annual report to holders ARS

Annual report to holders

May 1

Proxy statement DEFA14A

Proxy statement

Mar 1

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $405.36M ▼ 24.7% Net loss $88.72M Diluted EPS -$4.36

Feb 28

Earnings call

Q4 2022 earnings call

Feb 28

Current report 8-K

Financial results

Feb 8

Current report 8-K Events of Feb 3

Director or officer change, or executive pay

Jan 24

Current report 8-K

Financial results

Dec 19

Current report 8-K Events of Dec 13

Charter or bylaw amendment, or fiscal year change

Nov 14

Current report 8-K Events of Nov 8

Director or officer change, or executive pay, Regulation FD disclosure

Nov 8

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $53.38M ▼ 16.5% Net loss $39.15M Diluted EPS -$1.72

Nov 7

Earnings call

Q3 2022 earnings call

Nov 7

Current report 8-K

Financial results

Oct 5

Current report 8-K Events of Sep 29

Director or officer change, or executive pay

Aug 24

Registration statement S-3

Registration statement

Aug 22

Current report 8-K Events of Aug 16

Entered into a material agreement

Aug 9

Current report 8-K/A Events of Aug 3

Financial results

Aug 9

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $50.41M ▼ 47.8% Net loss $37.5M Diluted EPS -$1.65

Aug 8

Earnings call

Q2 2022 earnings call

Aug 8

Current report 8-K Events of Aug 3

Financial results, Director or officer change, or executive pay

Jun 21

Current report 8-K Events of Jun 15

Director or officer change, or executive pay, Shareholder vote results

Jun 2

Current report 8-K Events of May 31

Director or officer change, or executive pay

May 11

Proxy statement DEFA14A

Proxy statement